Party report and cash limits have curtailed the ability to meet such increases.
The increase in expenditure in real terms is no doubt due to several factors among which are the tendency to use higher doses of individual drugs or more drugs in combined regimens; real increases in the cost of some drugs; and the application of chemotherapy by an increasing number of clinicians to a progressively widening spectrum of cancers. These last two are probably the most important factors. There are now few cancers where chemotherapy is not being used to some degree, either speculatively or under clinical trial conditions; given the extreme complexity of many of the multi-drug regimens there seems much to be said on both clinical and economic grounds for them to be used primarily in the latter mode within the context of the multidisciplinary oncological team.
Increasing experience in the use of cytotoxic chemotherapy and in the control of toxicity have made this expansion feasible, and though results so far are perhaps rather disappointing, the possibility of a major advance in the management of solid tumours using cytotoxic drugs can by no means yet be discounted. This might come from the development of new ways of using existing drugs or from the discovery of new drugs.
The costs appear high but costs are relative. If, for example, there was clear evidence that spending £16 million on chemotherapy for breast cancer brought sufficient dividends in terms of lives saved or usefully prolonged then it might become a sustainable cost. If that cannot be demonstrated in respect of any cancer then the use of intensive chemotherapy becomes economically difficult to justify and difficult to justify also on clinical grounds in view of the high non-monetary costs of the treatment (British Medical Journal 1978) . The only way we can get the evidence required to make rational decisions on this is through good clinical trials. It is vitally important that there is a carefully coordinated programme of high quality clinical trials set up at the earliest opportunity in relation to any cancer where it is suggested that chemotherapy may be of benefit and for any new cytotoxic agent released for clinical use. It is an urgent problem and it is encouraging that coordination is already happening under the aegis of the Medical
Research Council and the Cancer Research
Campaign.
The results of these trials must of course be published as soon as a scientifically valid conclusion has been reached, but it is essential that early results are treated with the utmost caution. A very prolonged period of observation is necessary to demonstrate improved survival, the ultimate criterion of benefit, and long-term toxic effects (Williams & Carter 1978): without good evidence on both counts a great deal of highly toxic and expensive therapy may be given to no avail. Dermatitis herpetiformis and gluten enteropathy: a unifying concept'
Reports associating dermatitis herpetiformis (DH) and gluten enteropathy first appeared a decade or so ago. However, difficulties remain in correlating the pathogenesis of the two conditions. In order to overcome these difficulties reference should be made to published work, but it is also. necessary to make some assumptions which remain to be verified. Forty years ago, coeliac or Gee's disease was regarded as serious. Emphasis was placed on the malnourished patient, the often severe alimentary disturbance and the fatty stool. Then dietary gluten was established as its cause and the flattened mucosa was revealed by jejunal biopsy. It was also shown that gluten enteropathy might exist in patients with few or no alimentary symptoms. This The late Dr J Bronowski relates in 'The Ascent of Man' how cereals were cultivated and introduced into the diet only in relatively recent times. Adaptation to gluten of wheat, barley, rye and possibly oats is incomplete and, in the course of digestion, a potentially toxic and antigenic polypeptide may be formed. However, enough absorption to cause enteropathy occurs only in a very small minority, perhaps because protective immunoglobulin secreted into the intestinal lumen inactivates most of the toxic fraction. Much effort has gone into isolating and determining the chemical constitution of gluten, but the task is difficult because of the complexity of cereal proteins.
Preponderance of HLA-B8 and -Dw3 in patients with gluten enteropathy suggests that these histocompatibility antigens might act as receptors to the toxic compound and facilitate its absorption. However, there is little evidence for this and it is more likely that the loci of these antigens are closely linked on chromosome 6 with that of an Ir gene conferring susceptibility to gluten. Such concepts would accord with the hereditary factor in the aetiology of coeliac disease.
The interrelationships of the rash and the enteropathy of dermatitis herpetiformis remain highly speculative, but the following hypothesis, based on existing information, has the advantage that it can be readily tested by existing immunological techniques.
In coeliac patients, occurrence of DH depends upon a combination of circumstances. The intestinal lesion is often mild or patchy and jejunal biopsy may not reveal any enteropathy even when repeated several times (Marks 1977) . This may be because in coeliac patients who also have DH the active gluten fraction reacts within the intestinal mucosa mainly with the IgA-class antibody and in such a manner that soluble complexes are formed which diffuse into the circulation. These IgA complexes are of low affinity, are non-complement binding and unpalatable to the Kupfer cells and other macrophages. They are, therefore, only slowly cleared from the systemic circulation and pass from skin capillaries into the tissue spaces particularly at the tips of the papillae. Here, perhaps because of cross-reaction between gluten and reticulin (Seah et al. 1972) , they become attached to the subepidermal reticulin fibres where the IgA moiety can be characteristically demonstrated by direct immunofluorescence. Thus, gluten-IgA complexes, themselves inert, build up in the skin, but here they are also constantly degraded into their constituent amino acids. However, the whole antigen moiety may also be liberated, a situation probably predominating when the rate of arrival of fresh complexes from the gut exceeds that at which they can be smoothly processed. So the gluten, now in the skin, is again in an active form and liable to cause damage.
The histological picture of DH suggests that the changes result from the action of enzymes released from neutrophil lysosomes, an effect probably induced by the later components of the complement cascade. Alternate-pathway activation of complement is a feature of DH (Seah et al. 1973 , Provost & Tomasi 1974 . Massie et al. (1977) have recently demonstrated that gluten itself activates the alternate pathway in vitro. DH lesions could, therefore, be produced by release of gluten from IgA complexes and the resultant effects of by-pass activation of complement. At the same time, in unaffected skin, the complexes are yielding harmless amino acids. Dapsone, sulphapyridine and inorganic arsenic may owe their therapeutic efficacy at least in part to reduction of the injurious action of released neutrophil enzymes. Mohammed et al. (1976) did not find IgA in circulating immune complexes of DH. However, they may have come up against technical difficulties for not all complexes are detected by current methods (Lancet 1977) and IgA-containing ones may not have been isolated. If a gluten-free diet fails to clear DH, this is accounted for by inadvertent ingestion of gluten, quite common in patients under dietary gluten restriction for coeliac disease (Baker et al. 1975) . By contrast, in a group of patients with DH placed on a gluten-free diet, who were highly motivated and who had been familiarized with the diet during admission to hospital, skin lesions either cleared completely or were suppressed on a lower dose of dapsone while, concomitantly, subepidermal IgA was demonstrably reduced and enteropathy ameliorated (Harrington & Read 1977 ) -impressive evidence for the pathogenic role of gluten in both gut and skin conditions. Temporary or permanent remission of DH, even though gluten continues to be ingested, may be attributed to change in the pattern of the immunological response. If the immune complexes come to contain mainly IgG or IgM they will be rapidly cleared from the circulation, or precipitating rather than soluble complexes may be formed in the intestinal mucosa. Alternatively, enhanced activity of the reticuloendothelial system would enable it to deal more adequately with circulating IgA complexes. In either circumstance gluten will no longer reach the skin. In the rare cases of DH where subepidermal IgA is not found (Marks 1977) , unconjugated gluten, absorbed from the gut into the circulation, may be reaching the skin, damaging it directly. The curricula and standards of (a) and (b) are broadly the responsibility of the General Medical Council and the universities; (c) to (e) are broadly the responsibility of the Royal Colleges and Faculties, coordinated through the Council for Postgraduate Medical Education. In the future training for the specialty of occupational medicine we must take (d) and also (c) into account.
Because there is more than one Royal College and Faculty concerned with medicine in the United Kingdom and because there are so many subspecialties in general medicine, a Joint Committee on Higher Medical Training (JCHMT) was set up in 1971. Its responsibilities are to lay down guidelines for training in the medical specialties; to approve posts suitable for training; and to award certificates of accreditation to those who have successfully completed training. Its composition is set out in its Second Report.
Occupational medicine is one of nineteen medical specialties represented on the JCHMT. Each specialty has a Specialist Advisory Committee with two members appointed by the JCHMT on recommendations from the Royal Colleges, and four members who are recommended by the appropriate specialist associationthe Society of Occupational Medicine in the case of occupational medicine.
The functions of the Specialist Advisory Committee (SAC) in Occupational Medicine are to recommend to the JCHMT the broad outline of training programmes leading to specialist accreditation; to recommend those training posts which should be approved for higher specialist training; to recommend those trainees who have satisfactorily completed a training programme for accreditation as specialists in occupational medicine; and to help Postgraduate Deans, through Specialty Advisers, by rotating trainees through appropriate posts to form suitable training programmes. So far as is possible the training requirements are similar to those for any other specialty, but obviously because occupational health services are not part of the National Health Service, there must be differences. These are kept as small as possible.
There are requirements for general professional training (GPT) in each medical specialty. These are normally three years' training at registrar level in general medicine leading to an MRCP (UK). Some occupational physicians come into the specialty from other branches of medicine, apart from general medicine. The requirements for GPT in occupational medicine are therefore flexibly drawn to allow training in subjects related to occupational medicine, and to allow alternatives to the Diploma of the MRCP, in individual cases.
Once GPT is completed the trainee can enrol for higher specialist training (HST). The basic requirements for HST are a four-year training programme at equivalent to senior registrar level in approved posts in various occupational health services to give broad experience of the different facets of occupational health, and a period of formal training in a university department of occupational medicine to gain knowledge of industrial law, toxicology, epidemiology, etc. Occupational medicine is concerned with the effect of work on health and of health on the capacity to work. Some training posts in industry would give extensive experience in the monitoring and control of chemical and physical hazards at work, while others would give experience in surveillance of health in relation to jobs where physical and mental fitness are particularly important, like transport in all its forms. Every industry has a different managerial structure, personnel policies and formal and informal relationships with trade unions. It is important that a trainee should rotate through a variety of posts to gain wide experience. The SAC, therefore, requires training to be in not less than two approved posts and in approving a post the SAC may recommend that it should be followed or preceded by a post giving complementary experience. The
